SBI Securities »

Novabay Pharmaceuticals shares owned by SBI Securities

Quarter-by-quarter ownership of Novabay Pharmaceuticals (SDEV) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Novabay Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Novabay Pharmaceuticals held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novabay Pharmaceuticals by SBI Securities

Quarter filed Position value Share count Share price at filing
2026-06-30 $426 406 1.05

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Apple (AAPL)
Micron Technology (MU)
Vanguard Total World Stock ETF Etf (VT)
Alphabet Inc Class A cs (GOOGL)
Tesla Motors (TSLA)
Direxion Daily Semi Bull 3X ETF Etf (SOXL)
Vanguard High Dividend Yield ETF Etf (VYM)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Inc Class C cs (GOOG)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)

View all positions for SBI Securities

Top funds holding Novabay Pharmaceuticals

BlackRock
Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
State Street Corporation
Northern Trust
Bank of New York Mellon
Renaissance Technologies
State of Wyoming
Jane Street
Two Sigma Investments
Vanguard Global Advisers
Tower Research Capital
SBI Securities
UBS Group

View all funds holding Novabay Pharmaceuticals